Stage Zero Health
Cambridge
About Stage Zero Health
Stage Zero Health is a personalized cancer prevention and early detection platform designed to identify cancer risk before disease develops. The company uses AI-driven, individualized risk scores that integrate genetic data, clinical history, lifestyle factors, and environmental exposures to determine who is at elevated risk and what action should be taken’earlier and more precisely than standard age-based screening guidelines. By shifting cancer care upstream, Stage Zero Health enables proactive screening, risk-appropriate monitoring, and guided prevention rather than reactive, late-stage treatment. The platform is built to support individuals, employers, and healthcare partners by improving early detection rates, reducing downstream treatment costs, and closing gaps created by one-size-fits-all screening protocols. Stage Zero Health operates as a software-driven platform with mobile and web experiences, providing personalized insights, navigation, and decision support while remaining diagnostic-agnostic. Founded in 2024, the company’s mission is to redefine how cancer risk is understood and managed’proactively, continuously, and at the individual level.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2026)
- Website: stagezerohealthcom
- Phone: 7817773197
Social Profiles
Canonical: https://fsome.com/organization/stage-zero-health-2248922 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.